Loading...
Market
Primary reason for publication of NIH study on puberty blockers by Dr. Olson-Kennedy by end of 2024?
2
Resolution / Starting Odds
Pressure from peers • 25%
Public demand • 25%
NIH requirement • 25%
Other • 25%
Statements from Dr. Olson-Kennedy or related publications
Story
Dr. Olson-Kennedy Withholds $9.7M NIH Study on Puberty Blockers, Fearing 'Weaponization'
Oct 23, 2024, 06:15 PM
Dr. Johanna Olson-Kennedy, head of America's largest youth gender clinic at Children's Hospital Los Angeles, is under scrutiny for withholding the results of a $9.7 million NIH-funded study that began in 2015 on the effects of puberty blockers on transgender youth. The long-running study reportedly found that puberty blockers did not improve the mental health of adolescents with gender dysphoria. In an interview with The New York Times, Dr. Olson-Kennedy stated, 'I do not want our work to be weaponized,' explaining her reluctance to publish the findings. This revelation has sparked controversy, with many accusing her of suppressing important scientific data for political reasons.
View original story
Similar markets
Leaked to media • 33%
Disclosed by NIH • 33%
Not disclosed • 34%
Yes • 50%
No • 50%
No Action Taken • 25%
Publication Mandated • 25%
Funding Reallocation • 25%
Other Outcome • 25%
Increased funding • 25%
Decreased funding • 25%
Funding remains the same • 25%
No funding • 25%
Proven safe and effective • 25%
Proven ineffective • 25%
Proven unsafe • 25%
Inconclusive results • 25%
Yes • 50%
No • 50%
Safe and effective • 25%
Unsafe • 25%
Inconclusive • 25%
Trial not completed • 25%